Sandbox/22

# Gas gangrene

# CHF

# Hypertension
-  Cohn JN, Archibald DG, Ziesche S, Franciosa JA, Harston WE, Tristani FE;  et al. (1986). "Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study". N Engl J Med. 314 (24): 154752. doi:10.1056/NEJM198606123142404. PMID 3520315.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link) .mw-parser-output cite.citation{font-style:inherit}.mw-parser-output q{quotes:"\"""\"""'""'"}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-lock-free a{background:url("")no-repeat;background-position:right .1em center}.mw-parser-output .cs1-lock-limited a,.mw-parser-output .cs1-lock-registration a{background:url("")no-repeat;background-position:right .1em center}.mw-parser-output .cs1-lock-subscription a{background:url("")no-repeat;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{display:none;font-size:100%}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}
-  Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJ, Michelson EL;  et al. (2003). "Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme". Lancet. 362 (9386): 75966. PMID 13678868.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)   Review in: ACP J Club. 2004 Mar-Apr;140(2):32-3
-  Naidu SS (2011). "Novel percutaneous cardiac assist devices: the science of and indications for hemodynamic support". Circulation. 123 (5): 53343. doi:10.1161/CIRCULATIONAHA.110.945055. PMID 21300961.
-  Birks EJ, Tansley PD, Hardy J, George RS, Bowles CT, Burke M;  et al. (2006). "Left ventricular assist device and drug therapy for the reversal of heart failure". N Engl J Med. 355 (18): 187384. doi:10.1056/NEJMoa053063. PMID 17079761.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
-  Slaughter MS, Rogers JG, Milano CA, Russell SD, Conte JV, Feldman D;  et al. (2009). "Advanced heart failure treated with continuous-flow left ventricular assist device". N Engl J Med. 361 (23): 224151. doi:10.1056/NEJMoa0909938. PMID 19920051.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
-  Metra M, Torp-Pedersen C, Cleland JG, Di Lenarda A, Komajda M, Remme WJ, Dei Cas L, Spark P, Swedberg K, Poole-Wilson PA (2007). "Should beta-blocker therapy be reduced or withdrawn after an episode of decompensated heart failure? Results from COMET". European Journal of Heart Failure. 9 (9): 9019. doi:10.1016/j.ejheart.2007.05.011. PMID 17581778. Retrieved 2012-04-06. Unknown parameter |month= ignored (help)CS1 maint: Multiple names: authors list (link)
-  Gissi-HF Investigators. Tavazzi L, Maggioni AP, Marchioli R, Barlera S, Franzosi MG;  et al. (2008). "Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial". Lancet. 372 (9645): 122330. doi:10.1016/S0140-6736(08)61239-8. PMID 18757090.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)   Review in: Ann Intern Med. 2009 Jan 20;150(2):JC1-11